Boston Scientific Banks On ICDs To Spark Stock Growth; Index Slips In 2005
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is counting on Guidant shareholders preferring its takeover offer to J&J's to regain Wall Street enthusiasm in the face of diminishing competitive advantages for Taxus and a 31% stock decline in 2005